Combination therapy with Tamsulosin plus Dutasteride Versus Tamsulosin in Benign Prostatic Hyperplasia: a Systematic review & Meta-analysis
Background: This study aims to compare combination therapy efficacy and safety with tamsulosin plus dutasteride versus tamsulosin in benign prostatic hyperplasia. Methods: An online search was conducted in PubMed, Cochrane Library, Embase, Scopus, and Web of Science to identify the relevant publish...
Saved in:
Main Authors: | Behnam Amani (Author), Majid Davari (Author), Bahman Amani (Author), Arash Akbarzadeh (Author), Rouhollah Shabestan (Author) |
---|---|
Format: | Book |
Published: |
Tehran University of Medical Sciences,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparing monotherapy with tadalafil or tamsulosin in men with benign prostatic hyperplasia: A case-control study
by: Hayder Adnan Fawzi, et al.
Published: (2024) -
Effects of Cytochrome P450 and Transporter Polymorphisms on the Bioavailability and Safety of Dutasteride and Tamsulosin
by: Gonzalo Villapalos-García, et al.
Published: (2021) -
Additive effect of oral LDD175 to tamsulosin and finasteride in a benign prostate hyperplasia rat model
by: Choi BR, et al.
Published: (2018) -
Solifenacin/tamsulosin fixed-dose combination therapy to treat lower urinary tract symptoms in patients with benign prostatic hyperplasia
by: Dimitropoulos K, et al.
Published: (2015) -
PHARMACOECONOMIC ANALYSIS OF VESOMNI (SOLIFENACIN AND CONTROLLED RELEASE TAMSULOSIN) TREATMENT OF STORAGE SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA
by: N. A. Avxentyev, et al.
Published: (2016)